Welcome to our dedicated page for Nature’S Sun news (Ticker: NATR), a resource for investors and traders seeking the latest updates and insights on Nature’S Sun stock.
Nature’s Sunshine Products, Inc. reports company developments tied to its global natural health and wellness business, including herbal and nutritional supplements, personal care products, and its Synergy Worldwide division. News commonly covers quarterly results, gross margin and volume incentive trends, digital commerce, customer acquisition, auto-ship subscription programs, and performance across markets such as Asia, North America, Europe and Latin America.
Company updates also include executive appointments, supply chain and technology initiatives, and product-level announcements such as Pro-Argi-9+, Synergy’s L-arginine supplement for nitric oxide and circulation support.
Nature's Sunshine (Nasdaq: NATR) reported second quarter 2026 net sales of $117.0 million, up 2% year over year (4% in constant currency). Gross profit margin rose 194 basis points to 73.7%, while operating income increased to $5.5 million, or 4.7% of net sales, from $4.3 million a year ago.
GAAP net income attributable to common shareholders declined to $3.5 million, or $0.19 per diluted share, from $5.3 million, or $0.28 per diluted share, mainly due to lower other income and FX effects. Adjusted EBITDA was stable at $11.3 million. The company ended June 30, 2026 with $82.5 million in cash and no debt, after repurchasing 113,000 shares for $2.6 million. Reflecting FX headwinds and softness in China, full-year 2026 net sales guidance was revised to $490–$500 million (from $500–$515 million) and adjusted EBITDA to $48–$52 million (from $50–$54 million).
Nature’s Sunshine (NASDAQ:NATR) appointed Ruth Perkins as Executive Vice President and Chief Financial Officer, effective September 1, 2026. She will join the Growth Leadership Team and lead the global finance organization, covering financial planning and analysis, accounting, treasury, tax, internal audit, investor relations, and financial reporting.
Perkins brings over 20 years of finance leadership experience at major consumer companies, including The Estée Lauder Companies, PepsiCo, and Ford Motor Company. According to Nature’s Sunshine, her background in enterprise planning, transformation, supply chain finance, capital allocation, and value creation is expected to support the company’s strategy for sustainable, profitable growth.
Nature’s Sunshine (NASDAQ: NATR) appointed Janine Weber as Executive Vice President and President, North America, effective August 10, 2026. She will lead the company’s North American business, focusing on growth, consultant engagement, customer experience, and commercial strategy across the United States and Canada.
Weber brings over 25 years of leadership experience in direct selling, sales enablement, customer experience, and business development. She previously served as Regional President, North America at LifeWave, and held senior roles at Rodan + Fields during a period when it surpassed $1 billion in annual sales and was recognized by Euromonitor as North America’s leading skincare brand.
Nature’s Sunshine (Nasdaq: NATR) will host a conference call on Thursday, August 6, 2026, at 5:00 p.m. ET (3:00 p.m. MT) to discuss its second quarter 2026 financial results, which will be released in a press statement prior to the call.
The call, hosted by management with a Q&A session, can be accessed via toll-free dial-in 1-800-717-1738 or international 1-646-307-1865 using Conference ID 39783. A webcast and replay will be available via the Events section of the company’s website and by phone replay until August 20, 2026.
Nature's Sunshine (Nasdaq: NATR) reported Q1 2026 net sales of $122.9M, up 9%, GAAP EPS of $0.29 (up 16%), and Adjusted EBITDA of $14.6M, up 33%. Gross margin rose to 73.2%. Cash and cash equivalents were $87.6M with zero debt. Company repurchased 20,000 shares for $0.5M and reiterated 2026 guidance: $500–$515M net sales and $50–$54M adjusted EBITDA.
Nature’s Sunshine (NASDAQ: NATR) appointed John Hnanicek as Chief Technology Officer, effective May 4, 2026. He brings decades of senior technology, digital innovation, and e-commerce transformation experience, most recently as Chief Digital Innovation Officer at Melaleuca and prior senior roles at The Vitamin Shoppe.
Hnanicek will lead technology modernization, customer and consultant experience improvements, and support Nature’s Sunshine’s long-term growth strategy, reporting to the company’s executive leadership.
Nature’s Sunshine (Nasdaq: NATR) will host a conference call on Thursday, May 7, 2026 at 5:00 p.m. ET (3:00 p.m. MT) to discuss first-quarter results for the period ended March 31, 2026.
CEO Kenneth Romanzi and CFO Shane Jones will lead the call. A live webcast and replay will be available; replay runs through May 21, 2026.
Nature's Sunshine (Nasdaq: NATR) reported fourth quarter and full year 2025 results, with full year net sales of $480.1M (up 5.7%) and GAAP net income of $19.5M or $1.06 per diluted share. Adjusted EBITDA rose to $49.4M (+21.7%).
Q4 net sales were $123.8M (+4.7%), Q4 GAAP net income was $4.1M and cash was $93.9M with no debt. 2026 guidance: net sales $500–$515M; adjusted EBITDA $50–$54M.
Nature’s Sunshine (Nasdaq: NATR) will hold a conference call on Tuesday, March 10, 2026 at 5:00 p.m. Eastern / 3:00 p.m. Mountain to discuss fourth-quarter and full-year results for the period ended December 31, 2025.
CEO Kenneth Romanzi and CFO Shane Jones will host the call; a press release will precede the call and a replay will be available through March 24, 2026.
Nature's Sunshine (NASDAQ:NATR) division Synergy Worldwide announced that Euromonitor International named Pro-Argi-9+ the world’s #1 L-arginine supplement by retail sales value for 2024, based on custom research conducted Sept–Oct 2025.
Pro-Argi-9+ is described as an L-arginine complexer combining l-arginine and l-citrulline with polyphenols and antioxidants to support nitric oxide production, circulation, and cardiovascular wellness. Synergy cites the recognition as validation of its science-based nutrition strategy and global field distribution across Asia Pacific and other markets.